Weight loss pacemaker company Enteromedics gearing up for commercial launch

EnteroMedics ended 2014 in the red, though it gearing up commercialization plans for its signature neurostimulation anti-obesity implant.

EnteroMedics (NSDQ:ETRM) lost money again in 2014 but the Minnesota developer of a neurostimulation implant to treat obesity expects to address the red ink in the coming months, as it gears up for a commercial launch of its signature device.

EnteroMedics Inc.

News Well, Weight loss

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1DNO74q